PMID- 38539409 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240330 IS - 2227-9067 (Print) IS - 2227-9067 (Electronic) IS - 2227-9067 (Linking) VI - 11 IP - 3 DP - 2024 Mar 21 TI - Off-Label Yellow Fever and Hepatitis A Vaccination in Traveling Children. LID - 10.3390/children11030374 [doi] LID - 374 AB - There are few data on yellow fever (YF) and hepatitis A (HA) off-label vaccination. Given the rising trend of travel to endemic countries, there is a growing necessity to broaden vaccination coverage among the pediatric population. For this reason, we aim to assess the adverse effects associated with off-label vaccination, with the ultimate purpose of expanding the vaccine spectrum. We analyzed ambispectively ninety-four children under 12 months of age who received YF or HA off-label vaccines. The YF vaccine was administered to children aged 6-9 months and those allergic to eggs (with a prior negative prick test and no history of anaphylaxis), while the HA vaccine was given to children aged 6-12 months. Overall, 71 (75%) were vaccinated against YF, and 57 (60%) against HA; 34 against both. All of them fulfilled off-label vaccination criteria. No immediate adverse effects (AEs) were reported. Mild common AEs (diarrhea, fever, or malaise) were experienced by 10.8% of patients within 10 days after vaccination. The rate of AEs associated with off-label vaccination for HA and YF is low, suggesting that the vaccines could be considered safe. FAU - Muruzabal, Cecilia AU - Muruzabal C AUID- ORCID: 0009-0004-4301-096X AD - Pediatric and Infectious Diseases Department, La Paz University Hospital, 28046 Madrid, Spain. FAU - Vicente, Lorea AU - Vicente L AUID- ORCID: 0000-0002-3723-4885 AD - Pediatric and Infectious Diseases Department, La Paz University Hospital, 28046 Madrid, Spain. FAU - Escolano Taravillo, Lucia AU - Escolano Taravillo L AUID- ORCID: 0000-0002-6317-0336 AD - Pediatric and Infectious Diseases Department, La Paz University Hospital, 28046 Madrid, Spain. FAU - Bravo Queipo de Llano, Blanca AU - Bravo Queipo de Llano B AUID- ORCID: 0000-0001-8432-0703 AD - Pediatric and Infectious Diseases Department, La Paz University Hospital, 28046 Madrid, Spain. AD - La Paz Institute for Health Research (IdiPAZ), 28029 Madrid, Spain. FAU - Calvo, Cristina AU - Calvo C AUID- ORCID: 0000-0002-6503-3423 AD - Pediatric and Infectious Diseases Department, La Paz University Hospital, 28046 Madrid, Spain. AD - La Paz Institute for Health Research (IdiPAZ), 28029 Madrid, Spain. AD - Biomedical Research Network Centre for Infectious Diseases (CIBERINFEC), Carlos III Health Institute, 28029 Madrid, Spain. AD - Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain. FAU - Garcia Lopez Hortelano, Milagros AU - Garcia Lopez Hortelano M AUID- ORCID: 0000-0002-5028-1029 AD - Pediatric and Infectious Diseases Department, La Paz University Hospital, 28046 Madrid, Spain. AD - Biomedical Research Network Centre for Infectious Diseases (CIBERINFEC), Carlos III Health Institute, 28029 Madrid, Spain. AD - Pediatric Tropical Diseases Unit, International Adoption and Consultation of Traveling Children, La Paz University Hospital, 28046 Madrid, Spain. LA - eng PT - Journal Article DEP - 20240321 PL - Switzerland TA - Children (Basel) JT - Children (Basel, Switzerland) JID - 101648936 PMC - PMC10969183 OTO - NOTNLM OT - adverse effects OT - hepatitis A OT - off-label OT - vaccine OT - yellow fever COIS- The authors declare no conflicts of interest. EDAT- 2024/03/28 06:45 MHDA- 2024/03/28 06:46 PMCR- 2024/03/21 CRDT- 2024/03/28 01:01 PHST- 2024/02/21 00:00 [received] PHST- 2024/03/14 00:00 [revised] PHST- 2024/03/18 00:00 [accepted] PHST- 2024/03/28 06:46 [medline] PHST- 2024/03/28 06:45 [pubmed] PHST- 2024/03/28 01:01 [entrez] PHST- 2024/03/21 00:00 [pmc-release] AID - children11030374 [pii] AID - children-11-00374 [pii] AID - 10.3390/children11030374 [doi] PST - epublish SO - Children (Basel). 2024 Mar 21;11(3):374. doi: 10.3390/children11030374.